Farmabolsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2009-02-24
Share capital
50 000,00 PLN
Activity description

Farmabol offers diagnostic tests, including the Neosana blood pregnancy test, Amniocheck, the ND-10 test for drugs and designer drugs, and a CRP test. The company also develops the Neosana range of preparations and works with patients, pharmacies, and business and research partners in Poland, Europe, and the USA.

Registered address
Tadeusza Ociepki 4, 34-600 Limanowa, Poland
Website
farmabol.plWebsite active
Email
Email address current
Phone
Electronic delivery address
AE:PL-79249-69439-VEUCG-17

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 374.90kMedianUSD 72.17kAverageUSD 3.11m
Net profit
This companyUSD 1.43kMedianUSD 69.14AverageUSD 80.67k
Operating costs
This companyUSD 370.36kMedianUSD 75.48kAverageUSD 2.93m
Assets
This companyUSD 150.11kMedianUSD 121.09kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2010-01-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

23 public aid cases recorded, with a total value of $63,819.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,432
De minimis aid (in accordance with Commission Regulation 2023/2831)
$562
De minimis aid (in accordance with Commission Regulation 2023/2831)
$9,916

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Bolesław Witold Kurczab – V-Ce Prezes
Władysława Kurczab – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Bolesław Kurczab (45)
49$13,236.0998%
Others
1$270.122%

Beneficial owners

Person

Competitors

Name
Fibro-Labsp. z o.o.
Neuro Nutritionsp. z o.o.
Medicofarma BiotechS.A.
SKIN Lab Internationalsp. z o.o.
Medpolmatsp. z o.o.
Vitrotest Europesp. z o.o.
Nexbiosp. z o.o.
Countess Laboratoriessp. z o.o.
Pharmaxi Polandsp. z o.o.
Chemlabsp. z o.o.

Change history

DateEvent
2016-06-21PKD change
2010-03-18PKD change
2009-02-24Entered in the register

FAQ

Last updated: 2026-06-15